Recent Advances in Selected Orthopedic Oncology

Dear Colleagues,

Orthopedic oncology diseases are among the rare orphan diseases.  They affect patients of all age groups and include common benign and less common malignant tumors and both primary and metastatic diseases.  There have been many advances in the evaluation, diagnosis, and treatment of these conditions that warrant dissemination. This Special Issue presents articles on benign bone tumors (enostoses, low grade cartilage tumors, giant cell tumors of bone, fibrous dysplasia, intraosseous hemangiomas, osteoid osteomas, chondroblastomas, aneurysmal bone cysts), bone sarcomas (osteosarcomas, chondrosarcomas), metastatic bone disease, soft-tissue sarcomas, and benign soft tissue tumors (Tenosynovial Giant Cell Tumors).  Newer treatments will be discussed, including radiofrequency ablation, microwave ablation, embolization, percutaneous cementation, TNF-alpha inhibitors, CSF-1 receptor inhibitors, intensity modulated radiation therapy (IMRT), brachytherapy, intraoperative radiotherapy, 3-dimensional Conformal Radiation Therapy (3D-CRT), Stereotactic Body Radiation Therapy (SBRT), and immunotherapy. The multi-disciplinary nature of this Special Issue will be of interest to orthopedic oncologists, pediatric orthopedists, medical oncologists, radiation oncologists, musculoskeletal radiologists, interventional radiologists, and pathologists, reflecting the team approach needed for the diagnosis and treatment of these diseases.

Dr. Timothy Damron
Dr. Thomas R. Bowen
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.